Direct acting antivirals treatment for hepatitis C virus infection does not increase the incidence of de novo hepatocellular carcinoma occurrence
Antonio Riccardo Buonomo(University of Naples Federico II), Ivan Gentile(University of Naples Federico II), Stefania De Pascalis(University of Campania "Luigi Vanvitelli"), Giulio Viceconte(University of Naples Federico II), Costanza Maria Rapillo(Institute for Ethnic Studies), Laura Staiano, Mariantonietta Pisaturo(University of Antwerp), Riccardo Scotto(University of Naples Federico II), Nicola Coppola(University of Campania "Luigi Vanvitelli"), Ferdinando Scarano(Institute for Ethnic Studies), Salvatore Martini(University of Campania "Luigi Vanvitelli"), Mariarosaria Saturnino(Institute for Ethnic Studies), Biagio Pinchera, Grazia Tosone(University of Naples Federico II), Federica Portunato(Ospedale Policlinico San Martino), Carmine Coppola, Salvatore Nappa(University of Naples Federico II)
Cited by 9
Related Papers
Self-Reported Symptoms and Medication Side Effects Influence Adherence to Highly Active Antiretroviral Therapy in Persons With HIV Infection
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2001|470
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing <i>K. pneumoniae</i> Infections: A Retrospective Observational Multicenter Study
|Clinical Infectious Diseases|2021|264
Mortality Attributable to Bloodstream Infections Caused by Different Carbapenem-Resistant Gram-Negative Bacilli: Results From a Nationwide Study in Italy (ALARICO Network)
|Clinical Infectious Diseases|2023|156
Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients
|Diabetes & Metabolism|2020|138
Tocilizumab and steroid treatment in patients with COVID-19 pneumonia
|PLoS ONE|2020|128